• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 pandemic is not the time of trial and error.

作者信息

Mohamed Kawthar, Rezaei Nima

机构信息

Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran; Systematic Review and Meta-Analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.

Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.

出版信息

Am J Emerg Med. 2021 Aug;46:774-775. doi: 10.1016/j.ajem.2020.09.020. Epub 2020 Sep 14.

DOI:10.1016/j.ajem.2020.09.020
PMID:32988694
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7489261/
Abstract
摘要

相似文献

1
COVID-19 pandemic is not the time of trial and error.新冠疫情期间不是进行试验和错误尝试的时候。
Am J Emerg Med. 2021 Aug;46:774-775. doi: 10.1016/j.ajem.2020.09.020. Epub 2020 Sep 14.
2
The COVID-19 pandemic and a reflection on the conduct of clinical trials in times of war.新冠疫情与对战时临床试验开展情况的反思。
J Clin Epidemiol. 2021 Apr;132:131-132. doi: 10.1016/j.jclinepi.2020.12.008. Epub 2020 Dec 7.
3
Anticipating the Next Pandemic.预测下一场大流行病。
N Engl J Med. 2024 Jul 18;391(3):196-199. doi: 10.1056/NEJMp2403598. Epub 2024 Jul 13.
4
[An example of Clinical Investigations Center reorganization during the COVID-19 pandemic French national lockdown].[新冠疫情法国全国封锁期间临床研究中心重组的一个例子]
Therapie. 2021 Jul-Aug;76(4):347-358. doi: 10.1016/j.therap.2021.02.003. Epub 2021 Feb 14.
5
Clinical trial design during and beyond the pandemic: the I-SPY COVID trial.疫情期间及之后的临床试验设计：I-SPY COVID试验
Nat Med. 2022 Jan;28(1):9-11. doi: 10.1038/s41591-021-01617-x.
6
Peruvian COVID-19 vaccine scandal spreads.秘鲁新冠疫苗丑闻蔓延。
Lancet. 2021 Feb 27;397(10276):783. doi: 10.1016/S0140-6736(21)00508-0.
7
[The COVID-19 pandemic].[新冠疫情]
Med Mal Infect. 2020 Sep;50(8S):8S20-8S24. doi: 10.1016/S0399-077X(20)30779-4.
8
Sustained cancer clinical trial activity in a French hospital during the first wave of the COVID-19 pandemic.在新冠疫情第一波期间，一家法国医院持续开展癌症临床试验活动。
Cancer Cell. 2021 Aug 9;39(8):1039-1041. doi: 10.1016/j.ccell.2021.06.010. Epub 2021 Jun 18.
9
An expression of concern on research during the Covid-19 pandemic.关于新冠疫情期间研究的关注声明。
J Cardiovasc Med (Hagerstown). 2020 Oct;21(10):838-839. doi: 10.2459/JCM.0000000000001074.
10
Conducting Clinical Trials in the Time of a Pandemic.在大流行时期开展临床试验。
Ann Surg. 2020 Sep 1;272(3):e219-e221. doi: 10.1097/SLA.0000000000004114.

引用本文的文献

1
Mental Healthcare in Pediatrics During the COVID-19 Pandemic: A Call for International Public Health Action.儿科心理健康保健在 COVID-19 大流行期间：呼吁国际公共卫生行动。
Adv Exp Med Biol. 2024;1458:19-34. doi: 10.1007/978-3-031-61943-4_2.
2
Computed tomography scan in COVID-19: a systematic review and meta-analysis.新型冠状病毒肺炎的计算机断层扫描：一项系统综述和荟萃分析。
Pol J Radiol. 2022 Jan 5;87:e1-e23. doi: 10.5114/pjr.2022.112613. eCollection 2022.
3
Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies.干扰素治疗 SARS、MERS 和 COVID-19 患者：临床研究的系统评价和荟萃分析。
Eur J Pharmacol. 2021 Sep 5;906:174248. doi: 10.1016/j.ejphar.2021.174248. Epub 2021 Jun 12.
4
Altered immunoemotional regulatory system in COVID-19: From the origins to opportunities.COVID-19 中改变的免疫情绪调节系统：从起源到机遇。
J Neuroimmunol. 2021 Jul 15;356:577578. doi: 10.1016/j.jneuroim.2021.577578. Epub 2021 Apr 16.
5
A systematic review of pregnant women with COVID-19 and their neonates.对 COVID-19 孕妇及其新生儿的系统评价。
Arch Gynecol Obstet. 2021 Jul;304(1):5-38. doi: 10.1007/s00404-021-06049-z. Epub 2021 Apr 2.
6
Biosensing surfaces and therapeutic biomaterials for the central nervous system in COVID-19.用于新冠病毒肺炎中枢神经系统的生物传感表面和治疗性生物材料
Emergent Mater. 2021;4(1):293-312. doi: 10.1007/s42247-021-00192-8. Epub 2021 Mar 10.
7
Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review.计算药物发现和再利用治疗 COVID-19：系统评价。
Bioorg Chem. 2021 Jan;106:104490. doi: 10.1016/j.bioorg.2020.104490. Epub 2020 Nov 19.

本文引用的文献

1
Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review.计算药物发现和再利用治疗 COVID-19：系统评价。
Bioorg Chem. 2021 Jan;106:104490. doi: 10.1016/j.bioorg.2020.104490. Epub 2020 Nov 19.
2
Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.撤稿——羟氯喹或氯喹联合或不联合大环内酯类药物治疗新型冠状病毒肺炎：一项多国注册研究分析
Lancet. 2020 Jun 13;395(10240):1820. doi: 10.1016/S0140-6736(20)31324-6. Epub 2020 Jun 5.
3
SARS-CoV-2: A comprehensive review from pathogenicity of the virus to clinical consequences.SARS-CoV-2：从病毒的致病性到临床后果的全面综述。
J Med Virol. 2020 Oct;92(10):1864-1874. doi: 10.1002/jmv.26123. Epub 2020 Jun 19.
4
COVID-19: Transmission, prevention, and potential therapeutic opportunities.新型冠状病毒肺炎：传播、预防和潜在治疗机会。
Clin Chim Acta. 2020 Sep;508:254-266. doi: 10.1016/j.cca.2020.05.044. Epub 2020 May 29.
5
The involvement of the central nervous system in patients with COVID-19.COVID-19 患者的中枢神经系统受累情况。
Rev Neurosci. 2020 May 26;31(4):453-456. doi: 10.1515/revneuro-2020-0026.
6
The urgent need for integrated science to fight COVID-19 pandemic and beyond.应对新冠疫情等紧急情况需要综合科学。
J Transl Med. 2020 May 19;18(1):205. doi: 10.1186/s12967-020-02364-2.
7
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.瑞德西韦治疗成人重症 COVID-19 的随机、双盲、安慰剂对照、多中心临床试验。
Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29.
8
Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids.针对 COVID-19 的治疗规划：使用多种免疫抑制剂的原理和假设：抗抗体、免疫球蛋白和皮质类固醇。
Int Immunopharmacol. 2020 Jul;84:106560. doi: 10.1016/j.intimp.2020.106560. Epub 2020 May 8.
9
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.洛匹那韦-利托那韦治疗成人重症 COVID-19 患者的临床试验。
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
10
Drug repurposing: progress, challenges and recommendations.药物重定位：进展、挑战和建议。
Nat Rev Drug Discov. 2019 Jan;18(1):41-58. doi: 10.1038/nrd.2018.168. Epub 2018 Oct 12.